287 related articles for article (PubMed ID: 31264434)
1. Evolving Role of Genomics in Genitourinary Neoplasms.
Devitt ME; Dreicer R
Acta Med Acad; 2019 Apr; 48(1):68-77. PubMed ID: 31264434
[TBL] [Abstract][Full Text] [Related]
2. Practical Molecular Testing in a Clinical Genitourinary Service.
Magers MJ; Cheng L
Arch Pathol Lab Med; 2020 Mar; 144(3):277-289. PubMed ID: 31373513
[TBL] [Abstract][Full Text] [Related]
3. Current and Future Applications of Novel Immunotherapies in Urological Oncology: A Critical Review of the Literature.
Özdemir BC; Siefker-Radtke AO; Campbell MT; Subudhi SK
Eur Urol Focus; 2018 Apr; 4(3):442-454. PubMed ID: 29056275
[TBL] [Abstract][Full Text] [Related]
4. The germline mutational landscape of genitourinary cancers and its indication for prognosis and risk.
Yang Y; Zhang G; Hu C; Luo W; Jiang H; Liu S; Yang H
BMC Urol; 2022 Nov; 22(1):196. PubMed ID: 36451132
[TBL] [Abstract][Full Text] [Related]
5. Novel immunotherapy combinations for genitourinary cancers.
Al Harthy M; Redman J; Madan RA
Expert Opin Biol Ther; 2020 Mar; 20(3):253-262. PubMed ID: 31914333
[TBL] [Abstract][Full Text] [Related]
6. Genomic Sequencing Should Not be Part of the Standard of Care for Most Urologic Cancers.
Abern MR; Dudinec JV; Inman BA
Eur Urol Focus; 2022 May; 8(3):639-640. PubMed ID: 35537938
[TBL] [Abstract][Full Text] [Related]
7. Management of advanced genitourinary tumors.
Pietrantonio F; Biondani P; Verzoni E; Procopio G
Tumori; 2012; 98(2):264-6. PubMed ID: 22677995
[TBL] [Abstract][Full Text] [Related]
8. Perception of cure among patients with metastatic genitourinary cancer initiating immunotherapy.
Bergerot CD; Bergerot PG; Philip EJ; Hsu JA; Dizman N; Vaishampayan U; Dorff T; Pal SK
J Immunother Cancer; 2019 Mar; 7(1):71. PubMed ID: 30867071
[TBL] [Abstract][Full Text] [Related]
9. Molecular analysis of urothelial cancer cell lines for modeling tumor biology and drug response.
Nickerson ML; Witte N; Im KM; Turan S; Owens C; Misner K; Tsang SX; Cai Z; Wu S; Dean M; Costello JC; Theodorescu D
Oncogene; 2017 Jan; 36(1):35-46. PubMed ID: 27270441
[TBL] [Abstract][Full Text] [Related]
10. Renal Cell and Urothelial Carcinoma: Biomarkers for New Treatments.
Schmidt AL; Siefker-Radtke A; McConkey D; McGregor B
Am Soc Clin Oncol Educ Book; 2020 Mar; 40():1-11. PubMed ID: 32379987
[TBL] [Abstract][Full Text] [Related]
11. Genitourinary malignancies.
Michaelson MD; Smith MR
Cancer Chemother Biol Response Modif; 2003; 21():547-64. PubMed ID: 15338763
[No Abstract] [Full Text] [Related]
12. Adaptive Immunity in Genitourinary Cancers.
Koti M; Bivalacqua T; Black PC; Cathomen T; Galsky MD; Gulley JL; Ingersoll MA; Kamat AM; Kassouf W; Siemens DR; Gao J
Eur Urol Oncol; 2023 Jun; 6(3):263-272. PubMed ID: 37069029
[TBL] [Abstract][Full Text] [Related]
13. Recent advances in genitourinary tumors: A review focused on biology and systemic treatment.
González Del Alba A; Arranz JÁ; Puente J; Méndez-Vidal MJ; Gallardo E; Grande E; Pérez-Valderrama B; González-Billalabeitia E; Lázaro-Quintela M; Pinto Á; Lainez N; Piulats JM; Esteban E; Maroto Rey JP; García JA; Suárez C
Crit Rev Oncol Hematol; 2017 May; 113():171-190. PubMed ID: 28427506
[TBL] [Abstract][Full Text] [Related]
14. Biennial report on genitourinary cancers.
Fizazi K
Eur J Cancer; 2016 Oct; 66():125-30. PubMed ID: 27569040
[TBL] [Abstract][Full Text] [Related]
15. Exceptional response to everolimus in a novel tuberous sclerosis complex-2 mutation-associated metastatic renal-cell carcinoma.
Alsidawi S; Kasi PM
Cold Spring Harb Mol Case Stud; 2018 Apr; 4(2):. PubMed ID: 29610387
[TBL] [Abstract][Full Text] [Related]
16. Cabozantinib in genitourinary malignancies.
Zhang T; Park SE; Hong C; George DJ
Future Oncol; 2017 Apr; 13(8):755-765. PubMed ID: 27842445
[TBL] [Abstract][Full Text] [Related]
17. The Current Status and Future Role of the Phosphoinositide 3 Kinase/AKT Signaling Pathway in Urothelial Cancer: An Old Pathway in the New Immunotherapy Era.
Liu ST; Hui G; Mathis C; Chamie K; Pantuck AJ; Drakaki A
Clin Genitourin Cancer; 2018 Apr; 16(2):e269-e276. PubMed ID: 29199023
[TBL] [Abstract][Full Text] [Related]
18. Genitourinary cancer.
Hudes GR; Ozols RF; Schilder RJ
Cancer Chemother Biol Response Modif; 1991; 12():509-48. PubMed ID: 1718377
[No Abstract] [Full Text] [Related]
19. Present and future of personalized medicine in adult genitourinary tumors.
Ciccarese C; Santoni M; Massari F; Cheng L; Lopez-Beltran A; Scarpelli M; Conti A; Tortora G; Cascinu S; Montironi R
Future Oncol; 2015; 11(9):1381-8. PubMed ID: 25952784
[TBL] [Abstract][Full Text] [Related]
20. Targeting the Tumor Microenvironment with Immunotherapy for Genitourinary Malignancies.
Marciscano AE; Madan RA
Curr Treat Options Oncol; 2018 Mar; 19(3):16. PubMed ID: 29520448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]